DUBLIN--(BUSINESS WIRE)--The "End-Stage Renal Disease - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global End-Stage Renal Disease Market to Reach $155.4 Billion by 2027
Amid the COVID-19 crisis, the global market for End-Stage Renal Disease estimated at US$74.4 Billion in the year 2020, is projected to reach a revised size of US$155.4 Billion by 2027, growing at a CAGR of 11.1% over the analysis period 2020-2027.
Hemodialysis, one of the segments analyzed in the report, is projected to record a 12.3% CAGR and reach US$110.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peritoneal Dialysis segment is readjusted to a revised 9.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $20.1 Billion, While China is Forecast to Grow at 14.8% CAGR
The End-Stage Renal Disease market in the U.S. is estimated at US$20.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$34 Billion by the year 2027 trailing a CAGR of 14.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.6% and 9.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.
Other Treatment Types Segment to Record 8.1% CAGR
In the global Other Treatment Types segment, USA, Canada, Japan, China and Europe will drive the 7.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$12.5 Billion in the year 2020 will reach a projected size of US$20.8 Billion by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$22.6 Billion by the year 2027, while Latin America will expand at a 9.5% CAGR through the analysis period.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 42 Featured):
- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen AG
- Baxter International, Inc.
- BD
- Cantel Medical
- Fresenius Medical Care Ag & Co. KGAA
- Jms Co. Ltd
- Medtronic
- Nikkiso Co., Ltd.
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- World Current & Future Analysis for End-Stage Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- World Historic Review for End-Stage Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- World 15-Year Perspective for End-Stage Renal Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
- World 15-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
- World 15-Year Perspective for Peritoneal Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
- World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 42
For more information about this report visit https://www.researchandmarkets.com/r/zcal6b
